The importance of C1236T polymorphism in the ABCB1/MDR1 gene in assessment of susceptibility to inflammatory bowel diseases in the Polish population

Przeglad Gastroenterologiczny

Volumn 8, Issue 1, 2013, Pages 38-43

  Dudarewicz, Michal ^a   Baranska, Małgorzata ^a   Rychlik Sych, Mariola ^a   Trzcinski, Radzisław ^a   Dziki, Adam ^a   Skretkowicz, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Inflammatory bowel diseases; P glycoprotein

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; ENTERITIS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; RETROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS;

EID: 84878392663     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2013.34181     Document Type: Article

References (31)

1. Baranska M, Trzcinski R, Dziki A, et al. The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease. Dig Dis Sci 2011; 56: 2073-80.
2. Chojnacki C, Walecka-Kapica E, Klupińska G, et al. Evaluation of the influence of fluoxetine on the psychosomatic status of patients with ulcerative colitis. Probl Ter Monitor 2011; 22: 3-12.
3. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8: 458-66.
4. Dubois PC, van Heel DA. New susceptibility genes for ulcerative colitis. Nat Genet 2008; 40: 686-8.
5. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 2010; 6: 339-46.
6. Maconi G, Ardizzone S, Cucino C, et al. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010; 16: 4297-304.
7. Ince AT, Hatirnaz O, Ovünç O, et al. 1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci 2008; 53: 1683-92.
8. Papp M, Lakatos PL, Hungarian IBD Study Group, Palatka K, et al. Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in Hungarian patients. Dig Dis Sci 2007; 52: 1279-84.
9. Karban A, Hartman C, Eliakim R, et al. Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease. Dig Dis Sci 2007; 52: 2707-15.
10. Trzcinski R, Skretkowicz J, Dziki A, et al. Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease. Dig Dis Sci 2010; 55: 1037-43.
11. Balcerczak E, Panczyk M, Piaskowski S, et al. ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis 2010; 25: 1167-76.
12. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 2006; 234: 4-33.
13. Gümüş-Akay G, Rüstemoǧlu A, Karadaǧ A, et al. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population. Genet Mol Res 2008; 7: 1193-9.
14. Goto M, Masuda S, Saito H, et al. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Pharmacogenetics 2002; 12: 451-7.
15. Illmer T, Schuler US, Thiede C, et al. MDR1 Gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002; 62: 4955-62.
16. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001; 69: 169-74.
17. McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 100-13.
18. Kaczmarski M, Kurzawski M, Droździk M. Drug transporters. Probl Ter Monitor 2008; 19: 49-58.
19. Englund G, Jacobson A, Rorsman F, et al. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 2007; 13: 291-7.
20. Yacyshyn B, Maksymowych W, Bowen-Yacyshyn MB. Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis. Hum Immunol 1999; 60: 677-87.
21. Pechandová K, Buzková H, Slanař O, et al. Polymorphisms of the MDR1 gene in the Czech Population. Folia Biol (Praha) 2006; 52: 184-9.
22. Jeannesson E, Siest G, Bastien B, et al. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort. Clin Chim Acta 2009; 403: 198-202.
23. Jamroziak K, Balcerczak E, Calka K, et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res 2009; 33: 332-5.
24. Ieiri I, Takane H, Otsubo K. The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clin Pharmacokinet 2004; 43: 553-76.
25. Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, et al. Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol 2010; 79: 921-5.
26. Potocnik U, Ferkolj I, Glavac D, et al. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004; 5: 530-9.
27. Huebner C, Browning BL, Petermann I, et al. Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1784-93.
28. Krupoves A, Seidman EG, Mack D, et al. Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis 2009; 15: 900-8.
29. Juyal G, Midha V, Amre D, et al. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet Genomics 2009; 19: 77-85.
30. Oostenbrug LE, Dijkstra G, Nolte IM, et al. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol 2006; 41: 1174-82.
31. Osuga T, Sakaeda T, Nakamura T, et al. MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol Pharm Bull 2006; 29: 324-9.